Arabinogalactan- and dextran-induced ear inflammation in mice: differential inhibition by H1-antihistamines, 5-HT-serotonin antagonists and lipoxygenase blockers

Agents Actions. 1989 Aug;28(1-2):78-82. doi: 10.1007/BF02022984.

Abstract

Intravenous injection of arabinogalactan or dextran together with pontamine sky-blue dye into mice increased vascular permeability and led to marked blueing of the ears. Arabinogalactan caused a rapidly progressing ear blueing (maximal coloration 20-30 min after injection). This response was suppressed by pretreating the animals with the histamine H1-antihistamines levocabastine and loratadine. In contrast, dextran induced a slowly evolving ear inflammation (maximal coloration 60-90 min after injection), which was blocked by the 5-HT-serotonin antagonists cinanserin, metergoline and ritanserin. Furthermore, the dextran reaction was inhibited by the lipoxygenase (LO)/cyclooxygenase (CO) inhibitors BW540C, BW755C and phenidone and by the specific 5-LO inhibitor AA-861. Both arabinogalactan and dextran responses were inhibited by aprotinin, a kallikrein inhibitor, and the mixed H1/5-HT antagonists astemizole and azatadine. The inflammogenic activity of the polysaccharides was not affected by administration of the CO inhibitors indomethacin and suprofen, the thromboxane synthetase inhibitor dazoxiben, the H2-antihistamines cimetidine and ranitidine, the anticholinergics isopropamide or the PAF-antagonist L-652, 731. These data indicate the existence of distinctive endogenous molecules that mediate the pinnal extravasation reaction to both polysaccharides: histamine for arabinogalactan, serotonin and lipoxygenase-derived arachidonic acid metabolites for dextran.

MeSH terms

  • 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine
  • Animals
  • Aprotinin / therapeutic use
  • Astemizole
  • Benzimidazoles / therapeutic use
  • Benzoquinones*
  • Cinanserin / therapeutic use
  • Cyproheptadine / analogs & derivatives
  • Cyproheptadine / therapeutic use
  • Dextrans*
  • Galactans*
  • Histamine H1 Antagonists / therapeutic use*
  • Kinetics
  • Lipoxygenase Inhibitors*
  • Male
  • Metergoline / therapeutic use
  • Mice
  • Otitis / chemically induced
  • Otitis / prevention & control*
  • Piperidines / therapeutic use
  • Pyrazoles / therapeutic use
  • Quinones / pharmacology
  • Ritanserin
  • Serotonin Antagonists / therapeutic use*

Substances

  • Benzimidazoles
  • Benzoquinones
  • Dextrans
  • Galactans
  • Histamine H1 Antagonists
  • Lipoxygenase Inhibitors
  • Piperidines
  • Pyrazoles
  • Quinones
  • Serotonin Antagonists
  • Ritanserin
  • Metergoline
  • Cyproheptadine
  • 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine
  • Astemizole
  • 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone
  • BW 540C
  • Aprotinin
  • azatadine
  • phenidone
  • Cinanserin
  • arabinogalactan